Research Site

Rialto, California 92377

2 studies enrolling now · 10 studies all time

What they study most

COPD, Celiac Disease, Chronic Obstructive Pulmonary Disease, Hepatic Cirrhosis, Hepatic Impairment, Liver Fibrosis, Moderate Hepatic Impairment, Moderate to Very Severe COPD, Nonalcoholic Steatohepatitis

Studies at this site

• A Phase I Study to Investigate the Effect of Hepatic Impairment of AZD9550 and AZD6234 — Recruiting now
• A Phase I Study to Investigate the Pharmacokinetics and Safety of Capivasertib in Participants With Moderate Hepatic Impairment — Recruiting now
• A Study to Evaluate the Safety, Tolerability, PK, and PD Effects of AZD2389 in Participants With Liver Fibrosis and Compensated Cirrhosis. — Completed
• A Phase I Study to Investigate the Effect of Hepatic Impairment on the PK, Safety, and Tolerability of AZD2693 — Completed
• A Study to Evaluate AZD2693 in Participants Who Are Carriers of the PNPLA3 148M Risk Allele With Non-cirrhotic Non-alcoholic Steatohepatitis With Fibrosis — Completed
• Study to Investigate the Effect of Hepatic Impairment on the Pharmacokinetics, Safety, and Tolerability of AZD5004 — Completed
• A Study to Investigate the Effect of Hepatic Impairment on the Pharmacokinetics, Safety, and Tolerability of AZD2389 — Completed
• Pharmacokinetics of Mitiperstat in Participants With Hepatic Impairment — Completed
• Study to Evaluate the Efficacy and Safety of Larazotide Acetate for the Relief of CeD Symptoms — Stopped early
• Evaluate the Effect of Aclidinium Bromide on Long-term Cardiovascular Safety and Exacerbations in Moderate to Very Severe COPD Patients. — Completed